CD8A and myeloid sarcoma: Although the transcriptional phenotyping analyses suggest a pro-inflammatory, cytotoxic phenotype of CSF-expanded CD8+ T cells, further in vitro and in vivo analyses are needed to determine whether these cells are pathogenic in MS.